Tempus AI (NASDAQ:TEM) & Magnite (NASDAQ:MGNI) Head to Head Contrast

Tempus AI (NASDAQ:TEM) and Magnite (NASDAQ:MGNI) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, risk, valuation, dividends, institutional ownership, profitability and analyst recommendations.

Earnings & Valuation

This table compares Tempus AI and Magnite’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tempus AI	N/A	N/A	N/A	N/A	N/A
Magnite	$619.71 million	2.97	-$159.18 million	($0.64)	-20.56

Tempus AI has higher earnings, but lower revenue than Magnite.

Analyst Recommendations

This is a summary of recent ratings and target prices for Tempus AI and Magnite, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tempus AI	0	0	9	0	3.00
Magnite	0	0	12	0	3.00

Tempus AI presently has a consensus price target of $45.63, indicating a potential upside of 16.85%. Magnite has a consensus price target of $16.29, indicating a potential upside of 23.80%. Given Magnite’s higher probable upside, analysts plainly believe Magnite is more favorable than Tempus AI.

Institutional & Insider Ownership

73.4% of Magnite shares are owned by institutional investors. 4.3% of Magnite shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Tempus AI and Magnite’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tempus AI	N/A	N/A	N/A
Magnite	-12.24%	3.23%	0.87%

Summary

Magnite beats Tempus AI on 7 of the 8 factors compared between the two stocks.

About Tempus AI

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.

About Magnite

Magnite, Inc., together with its subsidiaries, operates an independent omni-channel sell-side advertising platform in the United States and internationally. The company's platform offers applications and services for sellers of digital advertising inventory or publishers that own and operate CTV channels, applications, websites, and other digital media properties to manage and monetize their inventory; and applications and services for buyers, including advertisers, agencies, agency trading desks, and demand side platforms to buy digital advertising inventory, as well as an independent marketplace that connects buyers and sellers. It markets its solutions through sales teams that operate from various locations. The company was formerly known as The Rubicon Project, Inc. and changed name to Magnite, Inc. in July 2020. Magnite, Inc. was incorporated in 2007 and is headquartered in New York, New York.